Dong Z, Crawford H C, Lavrovsky V, Taub D, Watts R, Matrisian L M, Colburn N H
Laboratory of Viral Carcinogenesis, National Cancer Institute, Frederick Cancer Research and Development Center, Maryland, USA.
Mol Carcinog. 1997 Jul;19(3):204-12. doi: 10.1002/(sici)1098-2744(199707)19:3<204::aid-mc8>3.0.co;2-d.
We previously reported that induced activator protein-1 (AP-1) transcriptional activity appears to be required for tumor promoter-induced transformation in mouse epidermal JB6 cells. To extend this investigation to a keratinocyte culture model and a transgenic mouse model, we constructed K14TAM67, a keratin 14 promoter-controlled version of the dominant negative jun mutant to directly block AP-1 activity and possibly indirectly block NF kappa B activity in basal squamous epithelia. This study was directed at characterizing TAM67 expression and biological activity in the mouse cell line 308, a keratinocyte model for studying carcinogenesis. Cotransfection of K14TAM67 with luciferase plasmid reporter DNAs produced inhibition of basal and 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced AP-1 and NF kappa B activity but had no effect on p53-dependent transcriptional activity. In an in vitro invasion assay, stable expression of TAM67 in 308 cells blocked TPA-induced Matrigel invasion. This suggests that blocking TPA-induced AP-1- or NF kappa B-regulated gene expression by TAM67 inhibits TPA-induced progression. Recombinant tissue inhibitor of metalloproteinase 1 reduced TPA-induced in vitro invasion, thus implicating metalloproteinases at least in part in the transcription factor-dependent process. Analysis of mRNA levels for members of the matrix metalloproteinase (MMP) family, however, revealed that the expression of any single MMP family member did not correlate with regulation of AP-1 or NF kappa B activity. However, the combination of substantial levels of mRNA for stromelysin-1, stromelysin-2, collagenase, membrane type 1 MMP, and gelatinase A occurred only in TPA-treated cells in the absence of TAM67. These results suggest that the action of the dominant negative jun mutant on AP-1 and NF kappa B gene regulation results in complex alterations in the levels of downstream effector genes, such as the metalloproteinases, that effect TPA-induced cellular invasion.
我们之前报道过,诱导激活蛋白-1(AP-1)转录活性似乎是肿瘤启动子诱导小鼠表皮JB6细胞转化所必需的。为了将这项研究扩展到角质形成细胞培养模型和转基因小鼠模型,我们构建了K14TAM67,即一种由角蛋白14启动子控制的显性负性jun突变体,以直接阻断AP-1活性,并可能间接阻断基底鳞状上皮中的核因子κB(NFκB)活性。本研究旨在表征TAM67在小鼠细胞系308中的表达及生物学活性,308是一种用于研究致癌作用的角质形成细胞模型。将K14TAM67与荧光素酶质粒报告DNA共转染,可抑制基础状态下以及12-O-十四烷酰佛波醇-13-乙酸酯(TPA)诱导的AP-1和NFκB活性,但对p53依赖的转录活性没有影响。在体外侵袭试验中,TAM67在308细胞中的稳定表达阻断了TPA诱导的基质胶侵袭。这表明TAM67阻断TPA诱导的AP-1或NFκB调控的基因表达可抑制TPA诱导的进展。重组金属蛋白酶组织抑制剂1降低了TPA诱导的体外侵袭,因此表明金属蛋白酶至少部分参与了转录因子依赖性过程。然而,对基质金属蛋白酶(MMP)家族成员mRNA水平的分析显示,任何单一MMP家族成员的表达与AP-1或NFκB活性的调控均无相关性。但是,仅在未用TAM67处理的TPA处理细胞中出现了高水平的基质溶解素-1、基质溶解素-2、胶原酶、膜型1 MMP和明胶酶A的mRNA组合。这些结果表明,显性负性jun突变体对AP-1和NFκB基因调控的作用导致了下游效应基因(如金属蛋白酶)水平的复杂改变,这些改变影响了TPA诱导的细胞侵袭。